U.S. FDA approves Hospira's docetaxel to treat variety of cancers
Links shared publicly online about this topic.
- 450total visits
U.S. FDA approves Hospira's docetaxel to treat variety of cancers
Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced U.S. Food and Drug Administration approval of docetaxel. The medication is a generic version of Sanofi-Aventis's Taxotere, and Hospira expects to launch the product later this month.
View full resource at news-medical.net
Tags: Cancer, Cancer Medication, Pharma, FDA, Taxotere, Oncology, News
Most Recently Shared on March 10, 2011 at 5:42 am By:
Oncology News: U.S. FDA approves Hospira's docetaxel to treat variety of cancers: Hospira, Inc., the world leade... http://bit.ly/fZkkTS
Advertisement
